Sponsors (3)
The bill strengthens U.S. tools to disrupt international synthetic-drug supply chains and gives law enforcement and financial actors clearer authority to block illicit flows, but it broadens reach and liability, raises compliance costs, and risks diplomatic and due-process consequences that could strain trade and complicate enforcement.
Law enforcement and the public: preserves and expands authority to block property and financial transactions of foreign actors tied to international synthetic-drug networks, disrupting revenue streams that fund trafficking and aiding investigations and asset forfeiture.
Law enforcement and border communities: requires prioritized intelligence and sustained presidential attention on PRC-linked suppliers of fentanyl precursors, improving investigations and potentially reducing fentanyl inflows at the border.
Financial institutions, taxpayers, and the federal government: strengthens financial-system protections and legal clarity for freezing or rejecting transactions tied to designated actors, prevents sanctioned foreign financial institutions from serving as primary dealers or holding U.S. government funds, and allows blocking government procurement from sanctioned persons.
All Americans and U.S. economic interests: broad sanctions, blocking authorities, and explicit focus on PRC-linked actors risk diplomatic and economic retaliation from China or other partners, which could harm trade and cooperation on broader issues.
Banks, businesses, government contractors, and small firms: expanded definitions (including foreign branches and persons located in the U.S.) and screening obligations will increase compliance costs, slow transactions, and may reduce business with some foreign customers or counterparties.
Individuals and companies (U.S. and foreign): the 'should have known' standard, reckless-disregard thresholds, and presidential determinations create heightened liability and limited procedural protections, increasing the risk of asset freezes, penalties, and contested designations for parties with tenuous or indirect ties.
Based on analysis of 6 sections of legislative text.
Expands U.S. sanction authorities—prioritizing PRC-linked actors—to block property, restrict finance, bar visas, and preserve Kingpin Act sanctions targeting fentanyl supply chains.
Official title: Impose sanctions with respect to persons that contribute to international trafficking of illicit drugs, including companies of the People's Republic of China that supply fentanyl precursors and certain cartels that traffic fentanyl into the United States, and for other purposes.
Introduced December 3, 2025 by Ben Ray Luján · Last progress December 3, 2025
Imposes and expands U.S. sanction authorities to target foreign persons and entities — especially those tied to the People’s Republic of China — involved in the manufacture, shipment, or financing of fentanyl, fentanyl precursors, and equipment used to produce illicit synthetic narcotics that are trafficked into the United States. The bill requires the President to prioritize identifying PRC-linked actors, preserves existing Kingpin Act sanctions on major Mexican transnational criminal organizations, and authorizes a range of blocking, financial, visa, procurement, and banking restrictions (using IEEPA and related authorities) against persons who materially contribute to international illicit synthetic narcotics trafficking.